Journal of Inherited Metabolic Disease

, Volume 24, Issue 2, pp 231–244 | Cite as

Liver repopulation for the treatment of metabolic diseases

  • M. Grompe


Orthotopic liver transplantation is the treatment of choice for several inborn errors of metabolism. Unfortunately, the supply of donor organs is limiting and therefore many patients cannot benefit from this therapy. In contrast, hepatocyte transplantation could potentially overcome the shortage in donor livers by use of cells from a single donor for multiple recipients. In classic hepatocyte transplantation, however, only 1% of the liver mass or less can be replaced by donor cells. Recently, though, it has been shown in animal models that >90% of host hepatocytes can be replaced by a small number of transplanted donor cells in a process we term ‘therapeutic liver repopulation’. This phenomenon is analogous to repopulation of the haematopoietic system after bone marrow transplantation. Liver repopulation occurs when transplanted cells have a growth advantage in the setting of damage to recipient liver cells. It has been discovered that transplanted cells from extrahepatic sources such as the adult pancreas or bone marrow can also be used for liver repopulation. Because bone marrow donors are widely available, this finding raises the hope of therapeutic application of these cells in the future. Here, the current knowledge regarding therapeutic liver repopulation and the hopeful implications for treatment of liver diseases will be discussed.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alison MR,Golding MH,Sarraf CE (1996) Pluripotential liver stem cells: facultative stem cells located in the biliary tree. Cell Prolif 29: 373–402.Google Scholar
  2. Alison MR,Poulsom R,Jeffery R, et al (2000) Hepatocytes from non-hepatic adult stem cells. Nature 406: 257.Google Scholar
  3. Baumann U,Crosby HA,Ramani P,Kelly DA,Strain AJ (1999) Expression of the stem cell factor receptor c-kit in normal and diseased pediatric liver: identi¢cation of a human hepatic progenitor cell? Hepatology 30: 112–117.Google Scholar
  4. Bucher NLR,Swaffeld MN (1964) The rate of incorporation of labeled thymidine into the deoxyribonucleic acid of regenerating rat liver in relation to the amount of liver excised. Cancer Res 240: 1611–1625.Google Scholar
  5. Busuttil RW,Klintmalm GB (1996) Transplantation of the Liver. Philadelphia: Saunders.Google Scholar
  6. Chen SJ,Tazelaar J,Moscioni AD,Wilson JM (2000) In vivo selection of hepatocytes transduced with adeno-associated viral vectors. Mol Ther 1: 414–422.Google Scholar
  7. De Vree JM,Ottenhoff R,Bosma PJ,Smith AJ,Aten J,Elferink RP (2000) Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology 119: 1720–1730.Google Scholar
  8. Edwards MA,Green A,Colli A,Rylance G (1987) Tyrosinaemia type I and hypertrophic obstructive cardiomyopathy. Lancet 1: 1437–1438.Google Scholar
  9. Ellis NA,Lennon DJ,Proytcheva M,Alhadeff B,Henderson EE,German J (1995) Somatic intragenic recombination within the mutated locus BLM can correct the high sister-chromatid exchange phenotype of Bloom syndrome cells. Am J Hum Genet 57: 1019–1027.Google Scholar
  10. Factor VM,Radaeva SA,Thorgeirsson SS (1994) Origin and fate of oval cells in dipin-induced hepatocarcinogenesis in the mouse. Am J Pathol 145: 409–422.Google Scholar
  11. Fox IJ,Chowdhury JR,Kaufman SS, et al (1998) Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 338: 1422–1426.Google Scholar
  12. Fujio K,Evarts RP,Hu Z,Marsden ER,Thorgeirsson SS (1994) Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in adult rat. Lab Invest 70: 511–516.Google Scholar
  13. Grisham JW (1962) A morphologic study of deoxyribonucleic acid synthesis and cell prolifer-ation in regenerating rat liver: autoradiography with thymidine-H3. Cancer Res 22: 842–849.Google Scholar
  14. Grompe M,Al-Dhalimy M,Finegold M, et al (1993) Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. Genes Dev 7: 2298–2307.Google Scholar
  15. Grompe M,Lindstedt S,al-Dhalimy M, et al (1995) Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I. Nature Genetics 10: 453–460.Google Scholar
  16. Grossman M,Raper SE,Kozarsky K, et al (1994) Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolemia. Nature Genetics 6: 335–341.Google Scholar
  17. Guha C,Sharma A,Gupta S, et al (1999) Amelioration of radiation-induced liver damage in partially hepatectomized rats by hepatocyte transplantation. Cancer Res 59: 5871–5874.Google Scholar
  18. Gupta S,Chowdhury JR (1994) Hepatocyte transplantation. In Arias IM ed. The LiveröBiology and Pathobiology, 3rd edn. New York: Raven Press, 1519–1536.Google Scholar
  19. Gussoni E,Soneoka Y,Strickland CD, et al (1999) Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401: 390–394.Google Scholar
  20. Hirschhorn R,Yang DR,Israni A,Huie ML,Ownby DR (1994) Somatic mosaicism for a newly identi¢ed splice-site mutation in a patient with adenosine deaminase-de¢cient immunode¢ciency and spontaneous clinical recovery. Am J Hum Genet 55: 59–68.Google Scholar
  21. Horwich AL (1991) Inherited hepatic enzyme defects as candidates for liver-directed gene therapy. Curr Top Microbiol Immunol 168: 185–200.Google Scholar
  22. Jackson KA,Mi T,Goodell MA (1999) Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci USA 96: 14482–14486.Google Scholar
  23. Jamal HZ,Weglarz TC,Sandgren EP (2000) Cryopreserved mouse hepatocytes retain regenerative capacity in vivo. Gastroenterology 118: 390–394.Google Scholar
  24. Jonkman MF,Scheffer H,Stulp R, et al (1997) Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion. Cell 88: 543–551.Google Scholar
  25. Kay MA,Woo SL (1994) Gene therapy for metabolic disorders. Trends Genet 10: 253–257.Google Scholar
  26. Kubo S,Sun M,Miyahara M, et al (1998) Hepatocyte injury in tyrosinemia type 1 is induced by fumarylacetoacetate and is inhibited by caspase inhibitors. Proc Natl Acad Sci USA 95: 9552–9557.Google Scholar
  27. Kvittingen EA (1991) Tyrosinaemia type Iöan update. J Inherit Metab Dis 14: 554–562.Google Scholar
  28. Kvittingen EA,Rootwelt H,Brandtzaeg P,Bergan A,Berger R (1993) Hereditary tyrosinemia type I. Self-induced correction of the fumarylacetoacetase defect. J Clin Invest 91: 1816–1821.Google Scholar
  29. Kvittingen EA,Rootwelt H,Berger R,Brandtzaeg P (1994) Self-inducd correction of the genetic defect in tyrosinemia type I. J Clin Invest 94: 1657–1661.Google Scholar
  30. Laconi E,Sarma DS,Pani P (1995) Transplantation of normal hepatocytes modulates the development of chronic liver lesions induced by a pyrrolizidine alkaloid, lasiocarpine. Carcinogenesis 16: 139–142.Google Scholar
  31. Laconi E,Oren R,Mukhopadhyay DK, et al (1998) Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am J Pathol 153: 319–329.Google Scholar
  32. Lagasse E,Connors H,Al-Dhalimy M, et al (2000) Puriffed hematopoietic stem cells can di¡erentiate into hepatocytes in vivo. Nature Medicine 6: 1229–1234.Google Scholar
  33. Le-Coultre C,Mentha G,Belli DC (1997) Liver transplantation in children: past, present and future. Eur J Pediatr Surg 7: 221–226.Google Scholar
  34. Lemire JM,Shiojiri N,Fausto N (1991) Oval cell proliferation and the origin of small hepatocytes in liver injury induced by D-galactosamine. Am J Pathol 139: 535–552.Google Scholar
  35. Lindblad B,Lindstedt S,Steen G (1977) On the enzymic defects in hereditary tyrosinemia. Proc Natl Acad Sci USA 74: 4641–4645.Google Scholar
  36. Lo Ten Foe JR,Kwee ML,Rooimans MA, et al (1997) Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. Eur J Hum Genet 5: 137–148.Google Scholar
  37. Manning K,Al-Dhalimy M,Finegold M,Grompe M (1999) In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I. Proc Natl Acad Sci USA 96: 11928–11933.Google Scholar
  38. Mattocks AR,Driver HE,Barbour RH,Robins DJ (1986) Metabolism and toxicity of synthetic analogues of macrocyclic diester pyrrolizidine alkaloids. Chem Biol Interact 58: 95–108.Google Scholar
  39. Michalopoulos GK,DeFrances MC (1997) Liver regeneration. Science 276: 60–66.Google Scholar
  40. Mignon A,Guidotti JE,Mitchell C, et al (1998) Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes. Nature Medicine 4: 1185–1188.Google Scholar
  41. Mitchell C,Mignon A,Guidotti JE, et al (2000) Therapeutic liver repopulation in a mouse model of hypercholesterolemia. Hum Mol Genet 9: 1597–1602.Google Scholar
  42. Mitchell GA,Grompe M,Lambert M,Tanguay RM (2001) Hypertyrosinemia. In Scriver CR,Beaudet AL,Sly W andValle D eds. The Metabolic and Molecular Basis of Inherited Disease. 8th edn. New York: McGraw-Hill, 1777–1805.Google Scholar
  43. Mitchell G,Larochelle J,Lambert M, et al (1990) Neurologic crises in hereditary tyrosinemia. N Engl J Med 322: 432–437.Google Scholar
  44. Ohmura T,Ledda-Columbano GM,Piga R, et al (1996) Hepatocyte proliferation induced by a single dose of a peroxisome proliferator. Am J Pathol 148: 815–824.Google Scholar
  45. Oren R,Dabeva MD,Karnezis AN, et al (1999a) Role of thyroid hormone in stimulating liver repopulation in the rat by transplanted hepatocytes. Hepatology 30: 903–913.Google Scholar
  46. Oren R,Dabeva MD,Petkov PM,Hurston E,Laconi E,Shafritz DA (1999b) Restoration of serum albumin levels in nagase analbuminemic rats by hepatocyte transplantation. Hepatology 29: 75–81.Google Scholar
  47. Overturf K,Al-Dhalimy M,Tanguay R, et al (1996) Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nature Genetics 12: 266–273.Google Scholar
  48. Overturf K,Al-Dhalimy M,Ou CN,Finegold M,Grompe M (1997a) Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol 151: 1273–1280.Google Scholar
  49. Overturf K,al-Dhalimy M,Ou CN, et al (1997b) Adenovirus-mediated gene therapy in a mouse model of hereditary tyrosinemia type I. Hum Gene Ther 8: 513–521.Google Scholar
  50. Overturf K,Al-Dhalimy M,Manning K,Ou CN,Finegold M,Grompe M (1998) Ex vivo hepatic gene therapy of a mouse model of hereditary tyrosinemia type I. Hum Gene Ther 9: 295–304.Google Scholar
  51. Overturf K,Al-Dhalimy M,Finegold M,Grompe M (1999) The repopulation potential of hepatocyte populations di¡ering in size and prior mitotic expansion. Am J Pathol 155: 2135–2143.Google Scholar
  52. Patijn GA,Lieber A,Schowalter DB,Schwall R,Kay MA (1998) Hepatocyte growth factor induces hepatocyte proliferation in vivo and allows for e¤cient retroviral-mediated gene transfer in mice. Hepatology 28: 707–716.Google Scholar
  53. Petersen BE,Bowen WC,Patrene KD, et al (1999) Bone marrow as a potential source of hepatic oval cells. Science 284: 1168–1170.Google Scholar
  54. Potten CS (1997) Stem Cells. London: Academic Press.Google Scholar
  55. Preisegger KH,Factor VM,Fuchsbichler A,Stumptner C,Denk H,Thorgeirsson SS (1999) Atypical ductular proliferation and its inhibition by transforming growth factor beta1 in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine mouse model for chronic alcoholic liver disease. Lab Invest 79: 103–109.Google Scholar
  56. Rajvanshi P,Kerr A,Bhargava KK,Burk RD,Gupta S (1996) Eficacy and safety of repeated hepatocyte transplantation for signi¢cant liver repopulation in rodents. Gastroenterology 111: 1092–1102.Google Scholar
  57. Rela M,Muiesan P,Heaton ND, et al (1995) Orthotopic liver transplantation for hepatic-based metabolic disorders. Transpl Int 8: 41–44.Google Scholar
  58. Rhim JA,Sandgren EP,Degen JL, et al (1994) Replacement of disease mouse liver by hepatic cell transplatation. Science 263: 1149–1152.Google Scholar
  59. Rozga J,Holzman M,Moscioni AD,Fujioka H,Morsiani E,Demetriou AA (1995) Repeated intraportal hepatocyte transplantation in analbuminemic rats. Cell Transplant 4: 237–243.Google Scholar
  60. Russo P,O'Regan S (1990) Visceral pathology of hereditary tyrosinemia type I. Am J Hum Genet 47: 317–324.Google Scholar
  61. Samuel A,Jago MV (1975) Localization in the cell cycle of the antimitotic action of the pyrrolizidine alkaloid, lasiocarpine and of its metabolite, dehydroheliotridine. Chem Biol Interact 10: 185–197.Google Scholar
  62. Sell S (1994) Liver stem cells. Mod Pathol 7: 105–112.Google Scholar
  63. Shinozuka H,Lombardi B,Sell S,Iammarino RM (1978) Early histological and functional alterations of ethionine liver carcinogenesis in rats fed a choline-de¢cient diet. Cancer Res 38: 1092–1098.Google Scholar
  64. Sun MS,Hattori S,Kubo S,Awata H,Matsuda I,Endo F (2000) A mouse model of renal tubular injury of tyrosinemia type 1: development of de Toni Fanconi syndrome and apoptosis of renal tubular cells in Fah/Hpd double mutant mice. J Am Soc Nephrol 11: 291–300.Google Scholar
  65. Theise ND,Badve S,Saxena R, et al (2000) Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 31: 235–240.Google Scholar
  66. Thorgeirsson SS (1996) Hepatic stem cells in liver regeneration. FASEB J 10: 1249–1256.Google Scholar
  67. Vrancken Peeters MJ,Patijn GA,Lieber A,Perkins J,Kay MA (1997) Expansion of donor hepatocytes after recombinant adenovirus-induced liver regeneration in mice. Hepatology 25: 884–888.Google Scholar
  68. Wang X,Al-Dhalimy M,Lagasse E,Finegold M,Grompe M (2001) Therapeutic liver reconstitution by transplanted adult mouse pancreatic cells. Am J Pathol, in press.Google Scholar
  69. Yoshida Y,Tokusashi Y,Lee GH,Ogawa K (1996) Intrahepatic transplantation of normal hepatocytes prevents Wilson's disease in Long-Evans cinnamon rats. Gastroenterology 111: 1654–1660.Google Scholar

Copyright information

© Kluwer Academic Publishers 2001

Authors and Affiliations

  • M. Grompe
    • 1
  1. 1.Department of Molecular and Medical Genetics, Department of PediatricsOregon Health Sciences UniversityPortlandUSA

Personalised recommendations